Elotuzumab, an MM drug that targets HLH-linked gene SLAMF7, has 5 PML cases reported in FAERS and for one case report the MM patient developed PML during treatment with lenalidomide and elotuzumab (93). This evidence concerns the gene SLAMF7 and progressive multifocal leukoencephalopathy.